“…Similar numbers of increased incidences of early or late AMD from 5 to 15 years after cataract surgery were published in other large epidemiological studies [29,30,31], except one [28]; Wang et al [27] reported an OR of 5.7–7.3 for late AMD incidence in pseudophakic patients after 5 years.…”
Section: Discussionsupporting
confidence: 76%
“…Similarly, an increased longtime risk of AMD or AMD progression was found for pseudophakic patients in several large epidemiological trials following patients for 5–15 years after cataract surgery [25,26,27,28,29,30,31,32,33]. Concerning quantitative AMD changes after cataract surgery, no large or prospective studies have been published so far.…”
Background/Aims: To monitor possible changes in the cumulated drusen or geographic atrophy area size (CDGAS) of nonexudative age-related macular degeneration (AMD) in patients before and after cataract surgery, using a new tool for computer-aided image quantification. Methods: Randomized, prospective, clinical trial. 54 patients with cataract and nonexudative AMD were randomly assigned into an early surgery group (ES = 28) and a control group (CO = 26) with a 6-month delay of surgery. CDGAS was determined with the MD3RI tool for contour drawing in a central region of digitized fundus photographs, measuring 3,000 µm in diameter. To evaluate CDGAS progression, differences in pixels and square millimeters were calculated by equivalent tests. Results: Forty-nine patients completed the visits over the 12-month period (ES = 27 and CO = 22). Mean pixel values increased from 201.5 (11.33 × 10–3 mm2) to 202.7 (11.39 × 10–3 mm2) in the ES group and from 191.6 (10.77 × 10–3 mm2) to 194.6 (10.94 × 10–3 mm2) in the CO group. Finally, equivalence of CDGAS differences between ES and CO could be demonstrated. No exudative AMD was recorded during the study period. Conclusion: In our cohorts, no significant changes were found in CDGAS 12 months after cataract surgery. The MD3RI software could serve as an efficient, precise and objective tool for AMD quantification and monitoring in future trials.
“…Similar numbers of increased incidences of early or late AMD from 5 to 15 years after cataract surgery were published in other large epidemiological studies [29,30,31], except one [28]; Wang et al [27] reported an OR of 5.7–7.3 for late AMD incidence in pseudophakic patients after 5 years.…”
Section: Discussionsupporting
confidence: 76%
“…Similarly, an increased longtime risk of AMD or AMD progression was found for pseudophakic patients in several large epidemiological trials following patients for 5–15 years after cataract surgery [25,26,27,28,29,30,31,32,33]. Concerning quantitative AMD changes after cataract surgery, no large or prospective studies have been published so far.…”
Background/Aims: To monitor possible changes in the cumulated drusen or geographic atrophy area size (CDGAS) of nonexudative age-related macular degeneration (AMD) in patients before and after cataract surgery, using a new tool for computer-aided image quantification. Methods: Randomized, prospective, clinical trial. 54 patients with cataract and nonexudative AMD were randomly assigned into an early surgery group (ES = 28) and a control group (CO = 26) with a 6-month delay of surgery. CDGAS was determined with the MD3RI tool for contour drawing in a central region of digitized fundus photographs, measuring 3,000 µm in diameter. To evaluate CDGAS progression, differences in pixels and square millimeters were calculated by equivalent tests. Results: Forty-nine patients completed the visits over the 12-month period (ES = 27 and CO = 22). Mean pixel values increased from 201.5 (11.33 × 10–3 mm2) to 202.7 (11.39 × 10–3 mm2) in the ES group and from 191.6 (10.77 × 10–3 mm2) to 194.6 (10.94 × 10–3 mm2) in the CO group. Finally, equivalence of CDGAS differences between ES and CO could be demonstrated. No exudative AMD was recorded during the study period. Conclusion: In our cohorts, no significant changes were found in CDGAS 12 months after cataract surgery. The MD3RI software could serve as an efficient, precise and objective tool for AMD quantification and monitoring in future trials.
“…It suggests that the development of cataract or cataract surgery did not markedly influence the development of age-related macular degeneration. Both these studies, however, are contradictory to a number of studies, including an investigation of autopsy eyes [36], several case series [37][38][39], and population-based epidemiologic studies [23,24,[40][41][42], in which concerns were raised with regard to the potential of cataract surgery to accelerate progression to advanced, vision-threatening forms of AMD.…”
In an intra-individual, inter-eye comparison, avoiding interdependencies of systemic parameters, inter-eye difference was not significantly associated with any characteristics of age-related macular degeneration in either any type of cataract or in pseudophakia. This suggests that the development of cataract or cataract surgery did not markedly influence the development of age-related macular degeneration.
“…Both conditions are quite common in the elderly and have overlapping symptoms, and deciding when to perform cataract surgery in patients with AMD can be difficult at best. Some clinicians believe that cataract surgery is beneficial in AMD patients whereas others fear that surgery could have deleterious effects; conflicting results from retrospective studies have led to further confusion regarding this issue (Kaiserman 2007;Sutter 2007).…”
Section: Overall Completeness and Applicability Of Evidencementioning
Background-Cataract and age-related macular degeneration (AMD) are common causes of decreased vision that often occur simultaneously in people over age 50. Although cataract surgery is an effective treatment for cataract-induced visual loss, some clinicians suspect that such an intervention may increase the risk of worsening of underlying AMD and thus have deleterious effects on vision.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.